tiprankstipranks
Advertisement
Advertisement
Femasys Amends Financing Terms and Issues New Warrants
PremiumCompany AnnouncementsFemasys Amends Financing Terms and Issues New Warrants
1M ago
Femasys appoints Kenneth Eichenbaum to its Board of Directors
Premium
The Fly
Femasys appoints Kenneth Eichenbaum to its Board of Directors
2M ago
Femasys advances FemBloc to U.S. approval with initiation of trial enrollment
Premium
The Fly
Femasys advances FemBloc to U.S. approval with initiation of trial enrollment
2M ago
Femasys enters distribution partnership with OR Consulting
PremiumThe FlyFemasys enters distribution partnership with OR Consulting
3M ago
Femasys Receives Nasdaq Extension to Regain Listing Compliance
Premium
Company Announcements
Femasys Receives Nasdaq Extension to Regain Listing Compliance
4M ago
Femasys granted 180-day extension by Nasdaq to regain compliance
Premium
The Fly
Femasys granted 180-day extension by Nasdaq to regain compliance
4M ago
Femasys secures U.S. FDA clearance for FemVue Controlled device
PremiumThe FlyFemasys secures U.S. FDA clearance for FemVue Controlled device
5M ago
PharmaCyte sells Femasys stake, sees cash position rising to $20M
Premium
The Fly
PharmaCyte sells Femasys stake, sees cash position rising to $20M
5M ago
Femasys initiated with a Buy at Laidlaw
Premium
The Fly
Femasys initiated with a Buy at Laidlaw
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100